{"id":124615,"date":"2022-01-18T01:59:10","date_gmt":"2022-01-18T01:59:10","guid":{"rendered":"https:\/\/fin2me.com\/?p=124615"},"modified":"2022-01-18T01:59:10","modified_gmt":"2022-01-18T01:59:10","slug":"why-the-worlds-largest-ice-cream-company-is-betting-on-home-delivery-2","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/why-the-worlds-largest-ice-cream-company-is-betting-on-home-delivery-2\/","title":{"rendered":"Why the world's largest ice cream company is betting on home delivery"},"content":{"rendered":"

London (CNN Business)<\/cite>Unilever<\/span> (UL<\/span>)<\/span> is willing to pay big money for the company that makes products like Advil, Tums and Aquafresh toothpaste as it tries to <\/strong>revive its sluggish stock and ramp up its focus on health products.<\/p>\n

GlaxoSmithKline<\/span> (GLAXF<\/span>)<\/span> said over the weekend that it had received three “unsolicited” proposals from Unilever to acquire its consumer healthcare business, which it runs as a joint venture with Pfizer<\/span> (PFE<\/span>)<\/span>. The latest had a price tag of \u00a350 billion ($68 billion).
\nGSK has rejected the offers, which it said were too low. It’s planning to spin off the division <\/strong>later this year, under pressure from shareholders including hedge fund Elliott Investment Management.<\/p>\n